Valion Bio, Inc. Common Stock (NASDAQ:VBIO) Stock Short Interest Rises 99.8%

Valion Bio, Inc. Common Stock (NASDAQ:VBIO) saw a large increase in short interest in the month of October. As of October 30th, there was short interest totaling 230,766 shares, an increase of 99.8% from the October 15th total of 115,490 shares. Based on an average trading volume of 1,684,819 shares, the short-interest ratio is currently 0.1 days. Approximately 26.2% of the shares of the stock are sold short.

Valion Bio, Inc. Common Stock Price Performance

NASDAQ VBIO traded up $0.02 during trading hours on Friday, reaching $0.53. The company’s stock had a trading volume of 100,191 shares, compared to its average volume of 1,015,439. The stock has a market cap of $471,077.00, a PE ratio of -0.00 and a beta of 1.91. Valion Bio, Inc. Common Stock has a fifty-two week low of $0.47 and a fifty-two week high of $67.50. The company’s 50-day moving average is $1.66 and its two-hundred day moving average is $13.69. The company has a debt-to-equity ratio of 1.74, a quick ratio of 0.86 and a current ratio of 1.11.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on VBIO shares. Wall Street Zen lowered Valion Bio, Inc. Common Stock from a “hold” rating to a “sell” rating in a research note on Saturday. Weiss Ratings reiterated a “sell (e+)” rating on shares of Valion Bio, Inc. Common Stock in a research report on Thursday, October 15th. One investment analyst has rated the stock with a Sell rating. Based on data from MarketBeat.com, Valion Bio, Inc. Common Stock currently has a consensus rating of “Sell”.

Valion Bio, Inc. Common Stock Company Profile

Tivic Health Systems Inc. operates as a health tech company, focuses on developing and commercializing bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for the treatment of sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, such as BestBuy and FSAStore and through distributors. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.